← Back to Search

Behavioral Intervention

CareMeds Intervention for Acute Lymphoblastic Leukemia

N/A

Recruiting

Led By Elizabeth Bouchard, PhD

Research Sponsored by Roswell Park Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 3 years

Awards & highlights

Study Summary

"This trial will test if the CareMeds program is practical and well-received by a larger group of 100 people in different locations in Buffalo, NY, and Atlanta, GA."

Who is the study for?

This trial is for parents of children aged 3-9 with acute lymphoblastic leukemia (ALL), who are fluent in English or Spanish, understand the study's nature, and have signed consent. The child must be on home-based oral anti-cancer medication like 6-MP.Check my eligibility

What is being tested?

The CareMeds Intervention is being tested against usual care to see if it helps improve how well parents manage their child’s medication for ALL. This larger study involves multiple sites and aims to evaluate its acceptability and feasibility.See study design

What are the potential side effects?

Since this trial focuses on behavioral intervention rather than a medical treatment, there may not be direct side effects like those associated with drugs; however, participation could impact family routines or stress levels.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of the CareMeds 3 sessions

Secondary outcome measures

Behavioral Parenting skills

Oral Chemotherapy adherence

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CareMeds InterventionExperimental Treatment1 Intervention

Participants complete the CareMeds parent training sessions during weeks 2, 3 and 4.

Group II: Usual CareActive Control2 Interventions

Usual care consists of medical consultations and supportive care, The usual care group will serve as a delayed intervention/wait list group for which 3 parent training sessions will be offered during weeks 13 through 15.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,669 Previous Clinical Trials

40,926,301 Total Patients Enrolled

Roswell Park Cancer InstituteLead Sponsor

402 Previous Clinical Trials

30,707 Total Patients Enrolled

Elizabeth Bouchard, PhDPrincipal InvestigatorRoswell Park Comprehensive Cancer Center

1 Previous Clinical Trials

79 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total number of participants currently under investigation in this clinical study?

"Yes, according to details on clinicaltrials.gov, this research study is actively seeking participants. The trial was initially listed on April 1st, 2024 and last revised on March 5th, 2024. Researchers aim to recruit a total of 100 patients from one designated site."

Answered by AI

Is the registration process currently ongoing for this clinical trial?

"The information provided on clinicaltrials.gov confirms that this research study is currently seeking eligible participants. Initially shared on April 1, 2024, the trial's most recent update was noted on March 5, 2024."

Answered by AI

Are individuals older than 60 years being included in the recruitment for this study?

"To be eligible for this research study, individuals between 3 and 9 years old are sought after. Notably, there are a total of 301 investigations focused on the pediatric population under 18 years old and another 298 trials catering to participants over the age of 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

2024. "Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06074666.